128 related articles for article (PubMed ID: 2025296)
1. Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme.
Ensor CM; Tai HH
Biochem Biophys Res Commun; 1991 Apr; 176(2):840-5. PubMed ID: 2025296
[TBL] [Abstract][Full Text] [Related]
2. Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Ensor CM; Tai HH
Biochim Biophys Acta; 1994 Sep; 1208(1):151-6. PubMed ID: 8086429
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme.
Ensor CM; Tai HH
Biochem Biophys Res Commun; 1996 Mar; 220(2):330-3. PubMed ID: 8645305
[TBL] [Abstract][Full Text] [Related]
4. Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
Zhou H; Tai HH
Biochem Biophys Res Commun; 1999 Apr; 257(2):414-7. PubMed ID: 10198228
[TBL] [Abstract][Full Text] [Related]
5. Threonine 11 of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD(+) during catalysis.
Cho H; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):505-9. PubMed ID: 12144871
[TBL] [Abstract][Full Text] [Related]
6. Expression of the cDNA for NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase as a catalytically active enzyme in Escherichia coli.
Ensor CM; Tai HH
Prostaglandins Leukot Essent Fatty Acids; 1992 Jul; 46(3):219-22. PubMed ID: 1508955
[TBL] [Abstract][Full Text] [Related]
7. Critical residues for the coenzyme specificity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
Cho H; Oliveira MA; Tai HH
Arch Biochem Biophys; 2003 Nov; 419(2):139-46. PubMed ID: 14592457
[TBL] [Abstract][Full Text] [Related]
8. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
Cho H; Huang L; Hamza A; Gao D; Zhan CG; Tai HH
Bioorg Med Chem; 2006 Oct; 14(19):6486-91. PubMed ID: 16828555
[TBL] [Abstract][Full Text] [Related]
9. Cloning and expression of the cDNA for mouse NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Matsuo M; Ensor CM; Tai HH
Biochim Biophys Acta; 1996 Nov; 1309(1-2):21-4. PubMed ID: 8950170
[TBL] [Abstract][Full Text] [Related]
10. Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.
Cho H; Hamza A; Zhan CG; Tai HH
Arch Biochem Biophys; 2005 Jan; 433(2):447-53. PubMed ID: 15581601
[TBL] [Abstract][Full Text] [Related]
11. Cysteine 182 is essential for enzymatic activity of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Ensor CM; Tai HH
Arch Biochem Biophys; 1996 Sep; 333(1):117-20. PubMed ID: 8806761
[TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of the cDNA for rat NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
Zhang H; Matsuo M; Zhou H; Ensor CM; Tai HH
Gene; 1997 Mar; 188(1):41-4. PubMed ID: 9099857
[TBL] [Abstract][Full Text] [Related]
13. Cloning and sequencing of a new 15-hydroxyprostaglandin dehydrogenase related mRNA.
Delage-Mourroux R; Pichaud F; Frendo JL; Pidoux E; Guliana JM; Moukhtar MS; Jullienne A
Gene; 1997 Mar; 188(1):143-8. PubMed ID: 9099873
[TBL] [Abstract][Full Text] [Related]
14. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.
Zhou H; Yan F; Tai HH
Eur J Biochem; 2001 Jun; 268(12):3368-74. PubMed ID: 11422365
[TBL] [Abstract][Full Text] [Related]
15. 15-Hydroxyprostaglandin dehydrogenase.
Ensor CM; Tai HH
J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):313-9. PubMed ID: 8777575
[TBL] [Abstract][Full Text] [Related]
16. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester.
Xun CQ; Tian ZG; Tai HH
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):553-8. PubMed ID: 1953649
[TBL] [Abstract][Full Text] [Related]
18. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.
Tai HH; Cho H; Tong M; Ding Y
Curr Pharm Des; 2006; 12(8):955-62. PubMed ID: 16533162
[TBL] [Abstract][Full Text] [Related]
19. Sequence of a novel mRNA coding for a C-terminal-truncated form of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Pichaud F; Frendo JL; Delage-Mourroux R; de Vernejoul MC; Moukhtar MS; Jullienne A
Gene; 1995 Sep; 162(2):319-22. PubMed ID: 7557451
[TBL] [Abstract][Full Text] [Related]
20. Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
Ensor CM; Yang JY; Okita RT; Tai HH
J Biol Chem; 1990 Sep; 265(25):14888-91. PubMed ID: 1697582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
